InvestorsHub Logo
Followers 13
Posts 795
Boards Moderated 0
Alias Born 03/03/2010

Re: None

Thursday, 12/07/2017 9:22:57 PM

Thursday, December 07, 2017 9:22:57 PM

Post# of 436
MediciNova Announces Positive Top-Line Results from the Clinical Trial of MN-166 (ibudilast) in ALS (https://finance.yahoo.com/m/e3f98ddc-820c-3c3a-8485-7f469aaf4c3a/medicinova-stock-up-more-than.html)

I do love MNOV. Because the price jumped over $10 after hours (before falling back)? Nope. It's progress in ALS research. There's no finer way to invest.

Kind regards,
Minding
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MNOV News